Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests that have a long history of meeting the needs of our customers in a highly convenient and cost-effective manner. The Intercept® oral fluid drug test is an FDA cleared laboratory-based oral fluid drug testing system that enables accurate testing for drugs of abuse. Companies around the globe choose Intercept for their testing programs for its fast and simple collection process eliminating the costs and dignity issues related to sample collection, reduction of sample tampering, and accurate results.
OraSure also manufactures and sells the OraSure® Oral Fluid Collection Device and laboratory testing assays for the detection of cotinine in oral fluid. Cotinine testing may be used in a number of situations to evaluate the possible use of tobacco products such as: smoking cessation programs, prospective employment screening, evaluations of applicants for health or life insurance and health and wellness programs.
In addition, OraSure offers the QED® saliva alcohol test. QED is a CLIA-waived and DOT approved on-site, rapid, low cost alternative to breath or blood testing. With a high correlation to blood alcohol levels, QED has a testing range of 0-145 mg/dL and provides quantitative results in minutes.